Search research articles
Contact Us
Filters
Showing results (1-10 of 258) with videos related to
Page
of 26
Sort By:
Frontiers in Pharmacology
|
July 31, 2023
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
Rafael Franco, Gemma Navarro
Frontiers in Psychiatry
|
March 30, 2018
Adenosine A<sub>2A</sub> Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Rafael Franco, Gemma Navarro
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 16, 2009
Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo
Gemma Navarro, Conchita Tros de Ilarduya
International Journal of Molecular Sciences
|
July 7, 2019
Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Molecular Pharmaceutics
|
January 6, 2015
Micelle-like nanoparticles as carriers for DNA and siRNA
Gemma Navarro, Jiayi Pan, Vladimir P Torchilin
Biomedicines
|
January 27, 2021
Dopamine in Health and Disease: Much More Than a Neurotransmitter
Rafael Franco, Irene Reyes-Resina, Gemma Navarro
Expert Opinion on Drug Discovery
|
February 19, 2019
Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
Rafael Franco, Eva Martínez-Pinilla, Gemma Navarro
International Review of Neurobiology
|
September 23, 2023
The adenosine A<sub>2A</sub> receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Antioxidants (Basel, Switzerland)
|
February 21, 2019
Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Antioxidants (Basel, Switzerland)
|
November 14, 2019
Antioxidants versus Food Antioxidant Additives and Food Preservatives
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Page
of 26
Search research articles
Search
Showing results (1-10 of 258) with videos related to
Sort By:
Page
of 26
Frontiers in Pharmacology
|
July 31, 2023
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
Rafael Franco, Gemma Navarro
Frontiers in Psychiatry
|
March 30, 2018
Adenosine A<sub>2A</sub> Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Rafael Franco, Gemma Navarro
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 16, 2009
Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo
Gemma Navarro, Conchita Tros de Ilarduya
International Journal of Molecular Sciences
|
July 7, 2019
Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Molecular Pharmaceutics
|
January 6, 2015
Micelle-like nanoparticles as carriers for DNA and siRNA
Gemma Navarro, Jiayi Pan, Vladimir P Torchilin
Biomedicines
|
January 27, 2021
Dopamine in Health and Disease: Much More Than a Neurotransmitter
Rafael Franco, Irene Reyes-Resina, Gemma Navarro
Expert Opinion on Drug Discovery
|
February 19, 2019
Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
Rafael Franco, Eva Martínez-Pinilla, Gemma Navarro
International Review of Neurobiology
|
September 23, 2023
The adenosine A<sub>2A</sub> receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Antioxidants (Basel, Switzerland)
|
February 21, 2019
Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Antioxidants (Basel, Switzerland)
|
November 14, 2019
Antioxidants versus Food Antioxidant Additives and Food Preservatives
Rafael Franco, Gemma Navarro, Eva Martínez-Pinilla
Page
of 26